vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $75.1M, roughly 1.1× SAUL CENTERS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -38.1%, a 46.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 10.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
BFS vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $75.1M | $83.1M |
| Net Profit | $6.5M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 65.4% | -4.1% |
| Net Margin | 8.7% | -38.1% |
| Revenue YoY | 10.6% | 20.2% |
| Net Profit YoY | -19.6% | -27.9% |
| EPS (diluted) | $0.15 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $75.1M | $76.4M | ||
| Q3 25 | $72.0M | $83.3M | ||
| Q2 25 | $70.8M | $79.2M | ||
| Q1 25 | $71.9M | $69.2M | ||
| Q4 24 | $67.9M | $68.2M | ||
| Q3 24 | $67.3M | $58.4M | ||
| Q2 24 | $66.9M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $6.5M | $-29.8M | ||
| Q3 25 | $10.5M | $-21.4M | ||
| Q2 25 | $10.7M | $-19.6M | ||
| Q1 25 | $9.8M | $-24.7M | ||
| Q4 24 | $8.1M | $-18.9M | ||
| Q3 24 | $14.5M | $-21.0M | ||
| Q2 24 | $14.4M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | 73.6% | 63.2% | ||
| Q2 24 | 74.2% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 65.4% | -40.6% | ||
| Q3 25 | 69.1% | -27.8% | ||
| Q2 25 | 68.7% | -28.0% | ||
| Q1 25 | 66.5% | -39.7% | ||
| Q4 24 | 82.9% | -28.9% | ||
| Q3 24 | 72.8% | -38.4% | ||
| Q2 24 | 75.0% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 8.7% | -39.1% | ||
| Q3 25 | 14.6% | -25.7% | ||
| Q2 25 | 15.1% | -24.7% | ||
| Q1 25 | 13.6% | -35.8% | ||
| Q4 24 | 11.9% | -27.6% | ||
| Q3 24 | 21.5% | -35.9% | ||
| Q2 24 | 21.6% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.15 | $-0.54 | ||
| Q3 25 | $0.32 | $-0.38 | ||
| Q2 25 | $0.33 | $-0.35 | ||
| Q1 25 | $0.29 | $-0.45 | ||
| Q4 24 | $0.22 | $-0.34 | ||
| Q3 24 | $0.48 | $-0.40 | ||
| Q2 24 | $0.48 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $245.6M |
| Total DebtLower is stronger | $468.4M | $51.7M |
| Stockholders' EquityBook value | $307.8M | $347.7M |
| Total Assets | $2.2B | $487.1M |
| Debt / EquityLower = less leverage | 1.52× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $8.7M | $286.5M | ||
| Q3 25 | $11.8M | $294.3M | ||
| Q2 25 | $5.3M | $302.7M | ||
| Q1 25 | $6.5M | $316.2M | ||
| Q4 24 | $10.3M | $333.7M | ||
| Q3 24 | $7.2M | $196.8M | ||
| Q2 24 | $6.9M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $468.4M | $51.6M | ||
| Q3 25 | $1.6B | $51.6M | ||
| Q2 25 | $1.6B | $51.5M | ||
| Q1 25 | $1.5B | $51.5M | ||
| Q4 24 | $455.8M | $51.5M | ||
| Q3 24 | $1.5B | $51.4M | ||
| Q2 24 | $1.4B | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $307.8M | $365.9M | ||
| Q3 25 | $316.6M | $380.3M | ||
| Q2 25 | $322.4M | $385.8M | ||
| Q1 25 | $328.4M | $389.2M | ||
| Q4 24 | $335.8M | $402.2M | ||
| Q3 24 | $341.8M | $241.2M | ||
| Q2 24 | $345.7M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $2.2B | $508.1M | ||
| Q3 25 | $2.2B | $511.5M | ||
| Q2 25 | $2.1B | $513.1M | ||
| Q1 25 | $2.1B | $519.4M | ||
| Q4 24 | $2.1B | $534.0M | ||
| Q3 24 | $2.1B | $374.1M | ||
| Q2 24 | $2.1B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 1.52× | 0.14× | ||
| Q3 25 | 5.02× | 0.14× | ||
| Q2 25 | 4.85× | 0.13× | ||
| Q1 25 | 4.70× | 0.13× | ||
| Q4 24 | 1.36× | 0.13× | ||
| Q3 24 | 4.37× | 0.21× | ||
| Q2 24 | 4.17× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 15.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $99.8M | $-10.3M | ||
| Q3 25 | $20.6M | $-6.6M | ||
| Q2 25 | $26.6M | $-15.0M | ||
| Q1 25 | $30.4M | $-17.0M | ||
| Q4 24 | $121.2M | $-32.4M | ||
| Q3 24 | $26.5M | $-18.8M | ||
| Q2 24 | $32.1M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | $-28.3M | $-19.0M | ||
| Q2 24 | $-12.5M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | -42.1% | -32.6% | ||
| Q2 24 | -18.7% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | 81.5% | 0.4% | ||
| Q2 24 | 66.7% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 15.35× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 2.48× | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 2.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFS
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |